PhD in cancer (Germany)

As a modern maximum-care hospital with a capacity of approximately 1,400 beds, the University Hospital of Cologne is dedicated to the practice of innovative academic medical excellence and assumes important societal functions in the fields of research, education and health care. The University Hospital of Cologne provides treatment to over 295,000 patients annually, with 58,000 of them receiving inpatient care. With a staff of about 10,200 employed by the hospital and subsidiary organizations, the University Hospital of Cologne is one of the largest employers in Cologne and ranks among the leading university clinics in Germany.

The „Translational Cancer Research Group“, a junior research group at the Department I of Internal Medicine (Hematology/Oncology), located at the university hospital Cologne, is seeking applications for a

PhD Student

to be employed immediately under a 3 year contract.

Our group is embedded in a highly dynamic research environment on the campus of the university hospital of Cologne, in immediate proximity to the CECAD  (Cologne Cluster of Excellence: Cellular Stress Responses in Aging-Associated Diseases) building and the CMMC (Center for Molecular Medicine Cologne), with state-of the-art equipment and the opportunity to access a range of excellent research facilities. Closely cooperating with international, national and local research partners we seek to better understand the molecular biology of cancer with the goal to provide a basis for the development of new treatment strategies for cancer patients.
We employ in vitro models and transgenic mice to analyze networks of cellular signaling and interactions within the tumor microenvironment of solid tumors. For this purpose, we pursue a multi-disciplinary and systems medicine approach. We cooperate with information scientists and pathologists, bringing together i) large datasets of our preclinical models and ii) human datasets from numerous clinically annotated patient samples of the CIO (Center of Integrated Oncology) Biobank in an integrative analysis.

Your responsibilities will include:
•       Planning and performing of research projects
•       Biochemical, molecular biological and cell biological tasks
•       Handling and tissue isolation of laboratory mice

Minimum qualifications:
•       Excitement for research
•       Profound understanding of cancer cell biology
•       Solid experience in basic methods of biochemistry, molecular biology and cell biology
•       Experience with laboratory mice
•       Good communication skills and the ability for teamwork

Your salary will be based on TV-L (60% E13).

The Board of Directors of the University Hospital of Cologne places strong emphasis on gender equality and seeks to increase the proportional representation of women in this field. Thus applications from female scientists are welcome; suitably qualified women will be given preferential consideration unless other candidates clearly demonstrate superior qualifications.

We also welcome applications from disabled candidates, who will also be given preferential consideration over other applicants with comparable qualifications.

The position is suitable for staffing with part-time employees.

Please address telephone enquiries to Dr. med. Tamina Seeger-Nukpezah at +49 221 478-86741.

Further information is available on the internet at
http://innere1.uk-koeln.de/forschung/translationale-krebsforschungsgruppe and http://miles.uni-koeln.de/

Have we awakened your interest? Please submit your application (including a detailed CV, list of publications, two references and a brief statement of research interests) here online
www.uk-koeln.de/karriere/stellenangebote

We prefer online applications, but you also have the opportunity to apply via regular mail quoting the reference number e145 until 17 May 2015 to

Uniklinik Köln
Klinik I für Innere Medizin
Dr. Tamina Seeger-Nukpezah
Ausschreibungsnummer e145
50924 Köln